scholarly journals What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children?

Author(s):  
Carmelo Gurnari ◽  
Mariadomenica Divona ◽  
Maria Teresa Voso
Leukemia ◽  
2004 ◽  
Vol 18 (10) ◽  
pp. 1576-1577 ◽  
Author(s):  
Y Ravindranath ◽  
J Gregory ◽  
J Feusner

2020 ◽  
Vol 49 (1) ◽  
pp. 308-308
Author(s):  
Ariella Barhen ◽  
Prithvi Raj Sendi Keshavamurthy ◽  
Paul Martinez ◽  
Balagangadhar Totapally

1995 ◽  
Vol 41 (4) ◽  
pp. 493-498 ◽  
Author(s):  
Kimitaka TAKITANI ◽  
Hiroshi TAMAI ◽  
Takao MORINOBU ◽  
Naohisa KAWAMURA ◽  
Munenori MIYAKE ◽  
...  

1981 ◽  
Vol 9 (1) ◽  
pp. 5-15 ◽  
Author(s):  
Ka Wah Chan ◽  
Peter G. Steinherz ◽  
Denis R. Miller

2012 ◽  
Vol 4 (1) ◽  
pp. e2012012 ◽  
Author(s):  
Li Zhang ◽  
Xiaofan Zhu

The limited available data suggest that the rate of early mortality is high and that long-term survival is poor in many developing countries. Death from bleeding and infection during chemotherapy, relapse and treatment abandonment are among the main cause of treatment failure in APL children. The status of children APL treatment in China is not described in general.


Sign in / Sign up

Export Citation Format

Share Document